Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Lucid Psycheceuticals Inc.

Tracked across 6 events · 39 articles · First seen Jun 02, 2026 · Last active Sep 11, 2026

Sentiment
18
Attention
6
Events
6
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 70
Tech
Impact: Lucid Psycheceuticals Inc. is a wholly owned subsidiary of Quantum BioPharma and is focused on the research and development of Lucid-MS.
Jun 08, 2026 · 8 articles
2 40
Tech
Quantum BioPharma received clearance from the U.S. United States — Food and Drug Administration to launch a phase 2 clinical trial of Lucid-MS, a patented first-in-class drug candidate for multiple sclerosis. Unlike existing MS therapies…
Impact: As Quantum BioPharma's wholly owned subsidiary, Lucid Psycheceuticals conducts the research and development of Lucid-MS, the compound at the center of the cleared trial.
Sep 09, 2026 · 6 articles
0 0
Business
Impact: Lucid Psycheceuticals Inc. is a wholly owned subsidiary of Quantum BioPharma, mentioned as the developer of Lucid-MS. The stock option grant does not directly affect Lucid, but it is part of the parent company's corporate update.
Aug 21, 2026 · 6 articles
2 0
Business
Impact: Lucid Psycheceuticals Inc. is a wholly owned subsidiary of Quantum BioPharma Ltd. focused on research and development of Lucid-MS.
Jun 02, 2026 · 6 articles
0 0
Business
Impact: Lucid Psycheceuticals Inc. is a wholly owned subsidiary of Quantum BioPharma focused on Lucid-MS. It is mentioned in the background but not directly involved in the event.
Jul 07, 2026 · 6 articles
0 0
Business
Impact: Lucid Psycheceuticals Inc. is a wholly owned subsidiary of Quantum BioPharma focused on Lucid-MS, but not directly involved in the debt settlement.
Jul 20, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Lucid Psycheceuticals Inc. live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.